Total Funding
64
61
Total FundingGrant raised
Growth Score
-3 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
121238
HAWK Biosystems is a cancer diagnostics platform.
- Banafshe Larijani: Co-founder, Joint Managing Director and CSO
- Peter J Parker: Co-Founder
About the Company
HAWK Biosystems is to be the platform in cancer diagnostics, bringing precision to cancer patient treatment. This will enable solution of the current problems, which lie in precisely targeting therapies to disease drivers. Fastbase provides a fast and efficient platform technology to measure drug target function. The benefits of precision medicine
that can be provided by Fastbase would be to deliver treatment to patients selected to respond to therapy, stop the treatment of patients who will not respond, improve patient outcomes and quality of life and also reduce drug costs. Fastbase will be a major player for collaborative opportunities with European Health system.
